RYTM - CIK 0001649904
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported revenue of $189.76M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $189.76M | +45.8% |
| FY 2024 | $130.13M | +68.1% |
| FY 2023 | $77.43M | +227.6% |
| FY 2022 | $23.64M | +649.5% |
| FY 2021 | $3.15M | - |
| FY 2018 | $0.00 | - |
| FY 2017 | $0.00 | - |
| FY 2016 | $0.00 | - |
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported revenue of $189.76M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, RHYTHM PHARMACEUTICALS, INC.'s revenue grew from $0.00 to $189.76M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.